サマリー

ヒトアルブミン注射液の世界市場規模は、2022年の百万米ドルから2029年には百万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。
ヒトアルブミン注射液の米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。
ヒトアルブミン注射液の中国市場は、2023年から2029年までのCAGRで、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
ヒトアルブミン注射液のヨーロッパ市場は、2023年から2029年にかけてのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
ヒトアルブミン注射剤の世界主要メーカーは、Octapharma、CSL Behring、Biotest (UK) Ltd、Baxter、Kedrion Biopharma, Inc、Grifols、GE HealthCare、Bio Products Laboratory、Green Crossなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
ヒトアルブミン溶液は、医療や外科のさまざまな問題で使用されています。
LPI（エルピーアイ）の最新リサーチレポート「ヒトアルブミン注射液の業界予測」は、過去の販売実績と2022年のヒトアルブミン注射液の世界総販売実績を調べ、2023年から2029年のヒトアルブミン注射液の販売予測について地域や市場分野ごとに包括的に分析したものである。ヒトアルブミン注射液の売上を地域別、市場分野別、サブセクター別に分類し、世界のヒトアルブミン注射液産業の詳細な分析を100万米ドル単位で提供します。
本インサイトレポートでは、世界のHuman Albumin Injectionの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、ヒトアルブミン注射剤のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要なグローバル企業の戦略を分析し、加速する世界のヒトアルブミン注射剤市場におけるこれらの企業の独自の地位をより良く理解することができます。
本インサイトレポートでは、ヒトアルブミン注射剤の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、機会の新たなポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界のヒトアルブミン注射剤の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のヒトアルブミン注射剤市場の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
血液抽出
リコンバイン
用途別セグメンテーション
病院
診療所
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
オクタファーマ
CSL ベーリング
ビオテスト（UK）社
バクスター
Kedrion Biopharma, Inc.
グリフォルス
GE ヘルスケア
バイオプロダクツラボラトリー
ミドリ十字
SKプラズマ
インスティテュート・グリフォルス
武田薬品工業
花蘭咲バイオ
南岳生物製薬（Nanyue Biopharmaceuticals
本レポートで取り上げる主な質問
ヒトアルブミン注射液の世界市場の10年後の展望は？
世界および地域別に、ヒトアルブミン注射液市場の成長を促進する要因は何か？
市場別、地域別で最も急成長する技術は何か？
ヒトアルブミン注射液の市場機会はエンドマーケットの規模によってどのように変化するのか？
ヒトアルブミン注射液のタイプ別、用途別の内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Albumin Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Albumin Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Albumin Injection by Country/Region, 2018, 2022 & 2029
2.2 Human Albumin Injection Segment by Type
2.2.1 Blood Extraction
2.2.2 Recombine
2.3 Human Albumin Injection Sales by Type
2.3.1 Global Human Albumin Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Human Albumin Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Albumin Injection Sale Price by Type (2018-2023)
2.4 Human Albumin Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Human Albumin Injection Sales by Application
2.5.1 Global Human Albumin Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Human Albumin Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Albumin Injection Sale Price by Application (2018-2023)
3 Global Human Albumin Injection by Company
3.1 Global Human Albumin Injection Breakdown Data by Company
3.1.1 Global Human Albumin Injection Annual Sales by Company (2018-2023)
3.1.2 Global Human Albumin Injection Sales Market Share by Company (2018-2023)
3.2 Global Human Albumin Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Human Albumin Injection Revenue by Company (2018-2023)
3.2.2 Global Human Albumin Injection Revenue Market Share by Company (2018-2023)
3.3 Global Human Albumin Injection Sale Price by Company
3.4 Key Manufacturers Human Albumin Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Albumin Injection Product Location Distribution
3.4.2 Players Human Albumin Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Albumin Injection by Geographic Region
4.1 World Historic Human Albumin Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Albumin Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Albumin Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Albumin Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Human Albumin Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Albumin Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Albumin Injection Sales Growth
4.4 APAC Human Albumin Injection Sales Growth
4.5 Europe Human Albumin Injection Sales Growth
4.6 Middle East & Africa Human Albumin Injection Sales Growth
5 Americas
5.1 Americas Human Albumin Injection Sales by Country
5.1.1 Americas Human Albumin Injection Sales by Country (2018-2023)
5.1.2 Americas Human Albumin Injection Revenue by Country (2018-2023)
5.2 Americas Human Albumin Injection Sales by Type
5.3 Americas Human Albumin Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Albumin Injection Sales by Region
6.1.1 APAC Human Albumin Injection Sales by Region (2018-2023)
6.1.2 APAC Human Albumin Injection Revenue by Region (2018-2023)
6.2 APAC Human Albumin Injection Sales by Type
6.3 APAC Human Albumin Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Albumin Injection by Country
7.1.1 Europe Human Albumin Injection Sales by Country (2018-2023)
7.1.2 Europe Human Albumin Injection Revenue by Country (2018-2023)
7.2 Europe Human Albumin Injection Sales by Type
7.3 Europe Human Albumin Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Albumin Injection by Country
8.1.1 Middle East & Africa Human Albumin Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Albumin Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Albumin Injection Sales by Type
8.3 Middle East & Africa Human Albumin Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Albumin Injection
10.3 Manufacturing Process Analysis of Human Albumin Injection
10.4 Industry Chain Structure of Human Albumin Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Albumin Injection Distributors
11.3 Human Albumin Injection Customer
12 World Forecast Review for Human Albumin Injection by Geographic Region
12.1 Global Human Albumin Injection Market Size Forecast by Region
12.1.1 Global Human Albumin Injection Forecast by Region (2024-2029)
12.1.2 Global Human Albumin Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Albumin Injection Forecast by Type
12.7 Global Human Albumin Injection Forecast by Application
13 Key Players Analysis
13.1 Octapharma
13.1.1 Octapharma Company Information
13.1.2 Octapharma Human Albumin Injection Product Portfolios and Specifications
13.1.3 Octapharma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Octapharma Main Business Overview
13.1.5 Octapharma Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Human Albumin Injection Product Portfolios and Specifications
13.2.3 CSL Behring Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Biotest (UK) Ltd
13.3.1 Biotest (UK) Ltd Company Information
13.3.2 Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications
13.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotest (UK) Ltd Main Business Overview
13.3.5 Biotest (UK) Ltd Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Human Albumin Injection Product Portfolios and Specifications
13.4.3 Baxter Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Kedrion Biopharma, Inc.
13.5.1 Kedrion Biopharma, Inc. Company Information
13.5.2 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications
13.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Kedrion Biopharma, Inc. Main Business Overview
13.5.5 Kedrion Biopharma, Inc. Latest Developments
13.6 Grifols
13.6.1 Grifols Company Information
13.6.2 Grifols Human Albumin Injection Product Portfolios and Specifications
13.6.3 Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Grifols Main Business Overview
13.6.5 Grifols Latest Developments
13.7 GE HealthCare
13.7.1 GE HealthCare Company Information
13.7.2 GE HealthCare Human Albumin Injection Product Portfolios and Specifications
13.7.3 GE HealthCare Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GE HealthCare Main Business Overview
13.7.5 GE HealthCare Latest Developments
13.8 Bio Products Laboratory
13.8.1 Bio Products Laboratory Company Information
13.8.2 Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications
13.8.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio Products Laboratory Main Business Overview
13.8.5 Bio Products Laboratory Latest Developments
13.9 Green Cross
13.9.1 Green Cross Company Information
13.9.2 Green Cross Human Albumin Injection Product Portfolios and Specifications
13.9.3 Green Cross Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Green Cross Main Business Overview
13.9.5 Green Cross Latest Developments
13.10 SK Plasma
13.10.1 SK Plasma Company Information
13.10.2 SK Plasma Human Albumin Injection Product Portfolios and Specifications
13.10.3 SK Plasma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SK Plasma Main Business Overview
13.10.5 SK Plasma Latest Developments
13.11 Instituto Grifols
13.11.1 Instituto Grifols Company Information
13.11.2 Instituto Grifols Human Albumin Injection Product Portfolios and Specifications
13.11.3 Instituto Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Instituto Grifols Main Business Overview
13.11.5 Instituto Grifols Latest Developments
13.12 Takeda
13.12.1 Takeda Company Information
13.12.2 Takeda Human Albumin Injection Product Portfolios and Specifications
13.12.3 Takeda Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Takeda Main Business Overview
13.12.5 Takeda Latest Developments
13.13 Hualan Bio
13.13.1 Hualan Bio Company Information
13.13.2 Hualan Bio Human Albumin Injection Product Portfolios and Specifications
13.13.3 Hualan Bio Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hualan Bio Main Business Overview
13.13.5 Hualan Bio Latest Developments
13.14 Nanyue Biopharmaceuticals
13.14.1 Nanyue Biopharmaceuticals Company Information
13.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications
13.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Nanyue Biopharmaceuticals Main Business Overview
13.14.5 Nanyue Biopharmaceuticals Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Human Albumin Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Albumin Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Blood Extraction
Table 4. Major Players of Recombine
Table 5. Global Human Albumin Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Human Albumin Injection Sales Market Share by Type (2018-2023)
Table 7. Global Human Albumin Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Human Albumin Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Human Albumin Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Human Albumin Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Human Albumin Injection Sales Market Share by Application (2018-2023)
Table 12. Global Human Albumin Injection Revenue by Application (2018-2023)
Table 13. Global Human Albumin Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Human Albumin Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Human Albumin Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Human Albumin Injection Sales Market Share by Company (2018-2023)
Table 17. Global Human Albumin Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Human Albumin Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Human Albumin Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Human Albumin Injection Producing Area Distribution and Sales Area
Table 21. Players Human Albumin Injection Products Offered
Table 22. Human Albumin Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Albumin Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Human Albumin Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Human Albumin Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Human Albumin Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Human Albumin Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Human Albumin Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Human Albumin Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Human Albumin Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Human Albumin Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Human Albumin Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Human Albumin Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Human Albumin Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Human Albumin Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Human Albumin Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Human Albumin Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Human Albumin Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Human Albumin Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Human Albumin Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Human Albumin Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Human Albumin Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Human Albumin Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Human Albumin Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Human Albumin Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Human Albumin Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Human Albumin Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Human Albumin Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Human Albumin Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Human Albumin Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Human Albumin Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Human Albumin Injection
Table 58. Key Market Challenges & Risks of Human Albumin Injection
Table 59. Key Industry Trends of Human Albumin Injection
Table 60. Human Albumin Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Human Albumin Injection Distributors List
Table 63. Human Albumin Injection Customer List
Table 64. Global Human Albumin Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Human Albumin Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Human Albumin Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Human Albumin Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Human Albumin Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Human Albumin Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Human Albumin Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Human Albumin Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Octapharma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Octapharma Human Albumin Injection Product Portfolios and Specifications
Table 80. Octapharma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Octapharma Main Business
Table 82. Octapharma Latest Developments
Table 83. CSL Behring Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring Human Albumin Injection Product Portfolios and Specifications
Table 85. CSL Behring Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CSL Behring Main Business
Table 87. CSL Behring Latest Developments
Table 88. Biotest (UK) Ltd Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications
Table 90. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Biotest (UK) Ltd Main Business
Table 92. Biotest (UK) Ltd Latest Developments
Table 93. Baxter Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Human Albumin Injection Product Portfolios and Specifications
Table 95. Baxter Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Baxter Main Business
Table 97. Baxter Latest Developments
Table 98. Kedrion Biopharma, Inc. Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications
Table 100. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Kedrion Biopharma, Inc. Main Business
Table 102. Kedrion Biopharma, Inc. Latest Developments
Table 103. Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Grifols Human Albumin Injection Product Portfolios and Specifications
Table 105. Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Grifols Main Business
Table 107. Grifols Latest Developments
Table 108. GE HealthCare Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. GE HealthCare Human Albumin Injection Product Portfolios and Specifications
Table 110. GE HealthCare Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. GE HealthCare Main Business
Table 112. GE HealthCare Latest Developments
Table 113. Bio Products Laboratory Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications
Table 115. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Bio Products Laboratory Main Business
Table 117. Bio Products Laboratory Latest Developments
Table 118. Green Cross Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Green Cross Human Albumin Injection Product Portfolios and Specifications
Table 120. Green Cross Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Green Cross Main Business
Table 122. Green Cross Latest Developments
Table 123. SK Plasma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. SK Plasma Human Albumin Injection Product Portfolios and Specifications
Table 125. SK Plasma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. SK Plasma Main Business
Table 127. SK Plasma Latest Developments
Table 128. Instituto Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Instituto Grifols Human Albumin Injection Product Portfolios and Specifications
Table 130. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Instituto Grifols Main Business
Table 132. Instituto Grifols Latest Developments
Table 133. Takeda Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Takeda Human Albumin Injection Product Portfolios and Specifications
Table 135. Takeda Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Takeda Main Business
Table 137. Takeda Latest Developments
Table 138. Hualan Bio Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Hualan Bio Human Albumin Injection Product Portfolios and Specifications
Table 140. Hualan Bio Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Hualan Bio Main Business
Table 142. Hualan Bio Latest Developments
Table 143. Nanyue Biopharmaceuticals Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications
Table 145. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Nanyue Biopharmaceuticals Main Business
Table 147. Nanyue Biopharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Human Albumin Injection
Figure 2. Human Albumin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Albumin Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Human Albumin Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Albumin Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Blood Extraction
Figure 10. Product Picture of Recombine
Figure 11. Global Human Albumin Injection Sales Market Share by Type in 2022
Figure 12. Global Human Albumin Injection Revenue Market Share by Type (2018-2023)
Figure 13. Human Albumin Injection Consumed in Hospital
Figure 14. Global Human Albumin Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Human Albumin Injection Consumed in Clinic
Figure 16. Global Human Albumin Injection Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Human Albumin Injection Sales Market Share by Application (2022)
Figure 18. Global Human Albumin Injection Revenue Market Share by Application in 2022
Figure 19. Human Albumin Injection Sales Market by Company in 2022 (K Units)
Figure 20. Global Human Albumin Injection Sales Market Share by Company in 2022
Figure 21. Human Albumin Injection Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Human Albumin Injection Revenue Market Share by Company in 2022
Figure 23. Global Human Albumin Injection Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Human Albumin Injection Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Human Albumin Injection Sales 2018-2023 (K Units)
Figure 26. Americas Human Albumin Injection Revenue 2018-2023 ($ Millions)
Figure 27. APAC Human Albumin Injection Sales 2018-2023 (K Units)
Figure 28. APAC Human Albumin Injection Revenue 2018-2023 ($ Millions)
Figure 29. Europe Human Albumin Injection Sales 2018-2023 (K Units)
Figure 30. Europe Human Albumin Injection Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Human Albumin Injection Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Human Albumin Injection Revenue 2018-2023 ($ Millions)
Figure 33. Americas Human Albumin Injection Sales Market Share by Country in 2022
Figure 34. Americas Human Albumin Injection Revenue Market Share by Country in 2022
Figure 35. Americas Human Albumin Injection Sales Market Share by Type (2018-2023)
Figure 36. Americas Human Albumin Injection Sales Market Share by Application (2018-2023)
Figure 37. United States Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Human Albumin Injection Sales Market Share by Region in 2022
Figure 42. APAC Human Albumin Injection Revenue Market Share by Regions in 2022
Figure 43. APAC Human Albumin Injection Sales Market Share by Type (2018-2023)
Figure 44. APAC Human Albumin Injection Sales Market Share by Application (2018-2023)
Figure 45. China Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Human Albumin Injection Sales Market Share by Country in 2022
Figure 53. Europe Human Albumin Injection Revenue Market Share by Country in 2022
Figure 54. Europe Human Albumin Injection Sales Market Share by Type (2018-2023)
Figure 55. Europe Human Albumin Injection Sales Market Share by Application (2018-2023)
Figure 56. Germany Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Human Albumin Injection Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Human Albumin Injection Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Human Albumin Injection Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Human Albumin Injection Sales Market Share by Application (2018-2023)
Figure 65. Egypt Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Human Albumin Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Human Albumin Injection in 2022
Figure 71. Manufacturing Process Analysis of Human Albumin Injection
Figure 72. Industry Chain Structure of Human Albumin Injection
Figure 73. Channels of Distribution
Figure 74. Global Human Albumin Injection Sales Market Forecast by Region (2024-2029)
Figure 75. Global Human Albumin Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Human Albumin Injection Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Human Albumin Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Human Albumin Injection Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Human Albumin Injection Revenue Market Share Forecast by Application (2024-2029)